Medication info
J-Grel Tablets (Clopidogrel Sulfate)

J-Grel Tablets (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201803080 · Approved 2018.07.25 · Insurance code 644914580

Summary

Main use
Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the day treatment with this product is initiated, start with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this product once daily. 3. For patients with atrial fibrillation, administer this product 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this product once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate hepatic disease and bleeding diathesis is limited. This product may be administered with or without food.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-Q wave myocardial infarction
  • cardiovascular anomalies
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation with low bleeding risk.
View approved original text

This medication is used to improve symptoms in adult patients with atherosclerotic symptoms such as ischemic stroke, myocardial infarction, and peripheral artery disease. It also helps to reduce the risk of death, myocardial infarction, and stroke caused by cardiovascular anomalies in patients with acute coronary syndrome and alleviates symptoms. For patients with atrial fibrillation where vitamin K antagonists are not appropriate and the risk of bleeding is low, it also reduces the risk of stroke and thrombosis. This medication is very effective in preventing cardiovascular diseases and thrombotic complications and is used for symptom improvement and prevention of disease recurrence.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the day treatment with this product is initiated, start with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this product once daily. 3. For patients with atrial fibrillation, administer this product 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this product once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate hepatic disease and bleeding diathesis is limited. This product may be administered with or without food.

Precautions

This medication prevents the aggregation of platelets in the blood and the formation of blood clots. The effectiveness may be reduced in individuals with genetically decreased function of a specific enzyme (CYP2C19), and alternative treatment options should be considered in such cases. It is advisable not to combine this medication with drugs that increase enzyme activity, as it could increase the risk of bleeding. Patients with allergies to this medication or its components, those with bleeding, severe liver damage, breastfeeding women, and those with lactose intolerance should not take this medication. Patients at risk for bleeding or those scheduled for surgery must consult a physician before taking this medication, and discontinuation is recommended 5 to 7 days prior to surgery. This medication may increase the risk of bleeding when used with other anticoagulant medications, so caution is required. If any bleeding symptoms or adverse reactions occur during use, medical personnel must be informed immediately, and regular blood tests may be necessary. Common side effects include gastrointestinal bleeding, skin rashes, headache, dizziness, abdominal pain, indigestion, diarrhea, nausea, high cholesterol, joint pain, low back pain, ecchymosis/bruising, nasal bleeding, depression, upper respiratory infections, rhinitis, bronchitis, cough, pruritus, urinary tract infections, chest pain, weight loss, weight gain, flushing, weakness, rigidity, facial swelling, syncope, reduced motor function, tremors, speech disorders, Particularly cautious use is required in elderly, underweight, liver disease, and kidney disorder patients, who should take it according to the physician's instructions. Women who are pregnant or breastfeeding should consult a physician before taking this medication and consider discontinuation or alternative treatment if necessary. Exceeding the recommended dose increases the risk of bleeding, so the specified dosage must be adhered to, and if overdose occurs, immediate hospital visit is necessary. This medication should be kept out of reach of children and should not be transferred to another container for safety.

Side effects

  • Hemorrhage
  • gastrointestinal bleeding
  • bleeding requiring hospitalization
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
Show 118 more
  • intracranial hemorrhage
  • major bleeding
  • life-threatening bleeding
  • fatal hemorrhage
  • hemorrhagic stroke
  • blood transfusion requirement
  • skin and appendage adverse reactions
  • neutropenia
  • agranulocytosis
  • aplastic anemia
  • thrombocytopenia
  • abdominal pain
  • dyspepsia
  • diarrhea
  • nausea
  • rash
  • pruritus
  • urinary tract infection
  • headache
  • dizziness
  • depression
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • myalgia
  • arthralgia
  • low back pain
  • depression
  • upper respiratory tract infection
  • gynecomastia
  • insomnia
  • anxiety
  • weight loss
  • weight gain
  • flushing
  • weakness
  • rigidity
  • facial swelling
  • syncope
  • blood in stool
  • thrombocytopenia
  • anemia
  • pneumonia
  • sinusitis
  • visual disturbances
  • visual field abnormalities
  • dry eye syndrome
  • temporary blindness
  • congestion
  • tinnitus
  • taste disturbances
  • voice disorders
  • abnormal gait
  • hyperkinesia
  • ataxia
  • hiccups
  • dysphagia
  • tongue disorders
  • abnormal behavior
  • rigidity
  • urination disorders
  • uremia
  • hypoglycemia
  • increased liver enzymes
  • elevated ALT
  • abnormal liver function
  • leg edema
  • arrhythmia
  • bradycardia
  • palpitations
  • rash
  • itching
  • contact dermatitis
  • elevated prostate-specific antigen
  • cholecystitis
  • hematemesis
  • spinal hematoma
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • herpes zoster
  • erythematous rash
  • maculopapular rash
  • urticaria
  • kidney function abnormalities
  • acute renal failure
  • confusion
  • hallucinations
  • loss of taste
  • angioedema
  • vesicular dermatitis
  • drug rash
  • eczema
  • lichen planus
  • arthritis
  • glomerulopathy
  • menorrhagia
  • hemothorax
  • herpes zoster
  • erythematous rash
  • maculopapular rash
  • urticaria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage helps to preserve the medication's effectiveness over time.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.